🏠 News Empire
health

India boosts domestic cardiac care with new cath lab manufacturing licence at AMTZ

Published on: 12 Jul 2026, 06:12 PM
India boosts domestic cardiac care with new cath lab manufacturing licence at AMTZ

Innvolution Healthcare Private Limited (IHPL) has received a manufacturing licence from the Central Drugs Standard Control Organisation (CDSCO) to produce cardiac catheterisation laboratories (cath labs) at the Andhra Pradesh MedTech Zone (AMTZ). The facility, recently inaugurated by Union Minister of Commerce and Industry Piyush Goyal, marks a significant step towards strengthening India's capacity to manufacture advanced cardiac imaging systems domestically.

This development comes amid a severe shortfall in cardiovascular infrastructure in India. Cardiovascular diseases claim nearly three million lives annually and affect an estimated 80 million patients. Currently, the country has only about 4,000 active cardiac cath labs, severely limiting access to advanced cardiac care. Experts believe that shifting from expensive imported systems to locally manufactured equipment will make treatments more affordable and expand their reach.

The cardiac care segment is one of India's fastest-growing medical device markets. Globally, the market for cath lab equipment and consumables is projected to grow from approximately $30-32 billion in 2026 to $50-55 billion over the next decade. Local production of these systems is expected to strengthen supply chains, create skilled jobs, reduce import dependence, and enhance India's global competitiveness in medical technology.

Dr. Jitendra Sharma, Managing Director and Founder CEO of AMTZ, hailed the achievement as a reflection of the growing maturity of India's MedTech ecosystem. 'At AMTZ, we remain committed to enabling world-class innovation and manufacturing that positions India as a global leader in advanced medical technologies,' he said.

Gaurav Agarwal, Managing Director of Innvolution Healthcare, highlighted the collaborative environment at the zone. 'The infrastructure and support available at AMTZ have enabled us to establish our cath lab manufacturing facility, and we remain committed to delivering reliable, high-quality solutions that meet the evolving needs of India's healthcare sector,' he stated.

Latest in Health 10
EU approval recognised for faster medical device access in India
health

EU approval recognised for faster medical device access in India

The Health Ministry has added the European Union to the list of trusted foreign regulators, allowing certain EU-approved medical devices to skip fresh clinical trials in India. Separate reforms ease sterilisation licensing and introduce fixed testing fees, aiming to reduce red tape and speed up device availability.

Times of India 25 Aug 2026, 04:40 PM
Read More →
Rajasthan suspends nine licences of IVF chain over blue foetus advertisement
health

Rajasthan suspends nine licences of IVF chain over blue foetus advertisement

Rajasthan health authorities have suspended nine registrations of Neelkanth Fertility and Women’s Care Hospital after a newspaper advertisement showed a blue-coloured foetus, seen as a prima facie indication of promoting sex selection. The action is taken under the Assisted Reproductive Technology (Regulation) Act, 2021, which bans sex-selective procedures.

The Hindu 25 Aug 2026, 04:01 PM
Read More →
→ View All Health News